1. Koo HL, Koo DC, Musher DM, DuPont HL. Antimotility Agents for the Treatment of Clostridium difficile Diarrhea and Colitis. Clin Infect Dis. 2009. 48(5):598–605. https://academic.oup.com/cid/article-lookup/doi/10.1086/596711
2. Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis. 2017. 65(12):1963–73.
3. Novak E. Unfavorable Effect of Atropine-Diphenoxylate (Lomotil) Therapy in Lincomycin-Caused Diarrhea. JAMA J Am Med Assoc, 1976. 235(14):1451. http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.1976.03260400017019
4. Kato H, Kato H, Nakamura M, Nakamura A. A case of toxic megacolon secondary to Clostridium difficile-associated diarrhea worsened after administration of an antimotility agent and molecular analysis of recovered isolates. J Gastroenterol. 2007. 42(6):507–8. http://www.ncbi.nlm.nih.gov/pubmed/17671768
5. Khanna S, Pardi DS. Clostridium difficile infection: new insights into management. Mayo Clin Proc. 2012. 87(11):1106–17. http://www.ncbi.nlm.nih.gov/pubmed/23127735
6. DuPont HL, Flores Sanchez J, Ericsson CD, Mendiola Gomez J, DuPont MW, Cruz Luna A, et al. Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea. Am J Med, 1990. 88(6A):15S–19S. http://www.ncbi.nlm.nih.gov/pubmed/2192553
7. DuPont HL, Ericsson CD, DuPont MW, Cruz Luna A, Mathewson JJ. A randomized, open-label comparison of nonprescription loperamide and attapulgite in the symptomatic treatment of acute diarrhea. Am J Med. 1990. 88(6A): 20S–23S. http://www.ncbi.nlm.nih.gov/pubmed/2192554
8. Dupont HL, Jiang ZD, Belkind-Gerson J, Okhuysen PC, Ericsson CD, Ke S, et al. Treatment of Travelers’ Diarrhea: Randomized Trial Comparing Rifaximin, Rifaximin Plus Loperamide, and Loperamide Alone. Clin Gastroenterol Hepatol. 2007;5(4):451–6.
9. Lääveri T, Sterne J, Rombo L, Kantele A. Systematic review of loperamide: No proof of antibiotics being superior to loperamide in treatment of mild/moderate travellers’ diarrhoea. Travel Med Infect Dis. 2016;14(4):299–312.
10. Kuntaman K, Lestari ES, Severin JA, Kershof IM, Mertaniasih NM, Purwanta M, et al. Fluoroquinolone-resistant Escherichia coli , Indonesia. Emerg Infect Dis. 2005. 11(9):1363–9. http://wwwnc.cdc.gov/eid/article/11/9/04-1207_article.htm
11. Yanagi D, de Vries GC, Rahardjo D, Alimsardjono L, Wasito EB, De I, et al. Emergence of fluoroquinolone-resistant strains of Salmonella enterica in Surabaya, Indonesia. Diagn Microbiol Infect Dis. 2009. 64(4):422–6. http://www.ncbi.nlm.nih.gov/pubmed/19631095